Danilo Rocco
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications
Corrigendum to 'Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational study' [Cancer Treat Res Commun. 2026:47:101143].
Journal: Cancer treatment and research communications
Published: August 25, 2026
Neoadjuvant therapy of NSCLC: a review of the use and impact of monoclonal antibodies.
Journal: Expert opinion on biological therapy
Published: September 05, 2025
Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry.
Journal: Journal for immunotherapy of cancer
Published: July 31, 2025
Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational study.
Journal: Cancer treatment and research communications
Published: March 24, 2025
Biologics for novel driver altered non-small cell lung cancer: potential and pitfalls.
Journal: Critical reviews in oncology/hematology
Published: March 06, 2025
Molecular determinants of sotorasib clinical efficacy in KRASG12C-mutated non-small-cell lung cancer.
Journal: Nature medicine
Published: January 27, 2025
A Cross-Sectional Study of Variant Interpretation and Reporting of NGS Data Using Tertiary Analysis Software: Navify® Mutation Profiler.
Journal: Oncology and therapy
Published: September 18, 2024
Neoadjuvant immunotherapy for lung cancer and hilar fibrosis during thoracoscopic lobectomy: Can we improve postoperative outcomes?
Journal: Annals of thoracic medicine
Published: June 16, 2024
An open-label, randomized phase III study of early switch maintenance vs delayed second-line nivolumab in advanced stage squamous non-small cell lung cancer (NSCLC) patients after standard first-line platinum-based chemotherapy-EDEN trial GOIRC 04-2016.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 06, 2024
Last Updated: 09/26/2026